Skip to main content
. 2017 Oct 30;2017(10):CD006491. doi: 10.1002/14651858.CD006491.pub4

3.18. Analysis.

3.18

Comparison 3 Mefloquine versus atovaquone‐proguanil, Outcome 18 Other adverse effects (cohort studies).